CRP and neoplasm: In univariable competing risk analysis, performance status, higher tumor stage, chemotherapy, non-seminomatous histology, large RPLN, higher IGCCCG risk classification, elevated tumor markers, CRP, fibrinogen and elevated Khorana score (i.e. > the 1 point assigned for testicular cancer) were significantly associated with an increased one-year risk of VTE (Table 4).